These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6360351)

  • 1. Early detection of breast cancer by leukocyte adherence inhibition assay.
    Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O
    Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular antitumor immune response in women with risk factors for breast cancer.
    Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S
    Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of leukocyte adherence inhibition assay in early detection of breast cancer.
    Kovarík J; Lauerová L; Kudlicková Z; Ninger E; Zemanová D
    Arch Geschwulstforsch; 1981; 51(4):344-8. PubMed ID: 7032450
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
    Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Counseling protocol for early cancer detection at the Women's Health Center in Ruma].
    Nedić B; Ravić J; Loncar S; Cuk D
    Med Pregl; 1999; 52(3-5):162-4. PubMed ID: 10518403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
    Storch H; Granetzny A
    Z Gesamte Inn Med; 1987 Jan; 42(2):41-4. PubMed ID: 3554795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
    Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
    Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer.
    Kubasova T; Bank J; Köteles GJ; Horváth M
    Neoplasma; 1990; 37(2):173-8. PubMed ID: 2188164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
    Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
    Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.